These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32243733)

  • 1. Effect of high ligation on survival of patients undergoing surgery for primary colorectal cancer and synchronous liver metastases.
    Matsui S; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Ishida T; Yamada T; Kondo T; Yamauchi S; Sugihara K; Kitagawa Y
    BJS Open; 2020 Jun; 4(3):508-515. PubMed ID: 32243733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
    Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
    Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Okuno M; Goumard C; Mizuno T; Kopetz S; Omichi K; Tzeng CD; Chun YS; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2018 Aug; 105(9):1200-1209. PubMed ID: 29664996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
    Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
    BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer.
    Scherman P; Syk I; Holmberg E; Naredi P; Rizell M
    BJS Open; 2020 Feb; 4(1):118-132. PubMed ID: 32011815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors of colorectal cancer patients with synchronous liver metastasis treated with simultaneous liver and colorectal resection].
    Wang Z; Zhou ZX; Liang JW; Bai XF; Bi JJ
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):372-5. PubMed ID: 18953839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
    Björnsson B; Sparrelid E; Røsok B; Pomianowska E; Hasselgren K; Gasslander T; Bjørnbeth BA; Isaksson B; Sandström P
    Eur J Surg Oncol; 2016 Apr; 42(4):531-7. PubMed ID: 26830731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
    Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
    Sadot E; Groot Koerkamp B; Leal JN; Shia J; Gonen M; Allen PJ; DeMatteo RP; Kingham TP; Kemeny N; Blumgart LH; Jarnagin WR; DʼAngelica MI
    Ann Surg; 2015 Sep; 262(3):476-85; discussion 483-5. PubMed ID: 26258316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.
    Hallet J; Sa Cunha A; Adam R; Goéré D; Bachellier P; Azoulay D; Ayav A; Grégoire E; Navarro F; Pessaux P;
    Br J Surg; 2016 Sep; 103(10):1366-76. PubMed ID: 27306949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival following delayed presentation and resection of colorectal liver metastases.
    Swan PJ; Welsh FK; Chandrakumaran K; Rees M
    Br J Surg; 2011 Sep; 98(9):1309-17. PubMed ID: 21598236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hepatectomy and hepatic pedicle lymphadenectomy in colorectal liver metastases is justified.
    Hodgson R; Sethi H; Ling AH; Lodge P
    HPB (Oxford); 2017 Jun; 19(6):525-529. PubMed ID: 28215513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
    Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.